| Family: | Invesco |
| Name: | Invesco Dorsey Wright Healthcare Momentum ETF |
| Inception Date: | 12-Oct-2006 |
| Termination Date: | |
| Investment Objective: | The Invesco Dorsey Wright Healthcare Momentum ETF (Fund) is based on the Dorsey Wright Healthcare Technical Leaders Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to identify companies that are showing relative strength (momentum), and is composed of at least 30 securities from the NASDAQ US Benchmark Index. Relative strength is the measurement of a security's performance in a given universe over time as compared to the performance of all other securities in that universe. The Fund and the Index are rebalanced and reconstituted quarterly. |
| Prospectus | |
| Top 10 Holdings | ||
| Roivant Sciences Ltd | ROIV | 4.9200% |
| Praxis Precision Medicines Inc | PRAX | 4.8500% |
| SELLAS Life Sciences Group Inc | SLS | 4.0800% |
| Tango Therapeutics Inc | TNGX | 3.7300% |
| United Therapeutics Corp | UTHR | 2.8500% |
| Tenet Healthcare Corp | THC | 2.7900% |
| Axsome Therapeutics Inc | AXSM | 2.6700% |
| Erasca Inc | ERAS | 2.5500% |
| Moderna Inc | MRNA | 2.5100% |
| BrightSpring Health Services Inc | BTSG | 2.4700% |
| Top 10 Holdings Weight: | 33.4% |
| Number of Holdings: | 59 |
| Shares Outstanding: | 2,250,000 |
| Total Net Assets: | 134,046,900 |
| NAV: | 59.56 |
| Net Expense Ratio: | 0.60% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | Other Quant Model |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
